SAMHD1 is mutated recurrently in chronic lymphocytic leukemia and is involved in response to DNA damage.
SAMHD1 is a deoxynucleoside triphosphate triphosphohydrolase and a nuclease that restricts HIV-1 in noncycling cells. Germ-line mutations in SAMHD1 have been described in patients with Aicardi-Goutières syndrome (AGS), a congenital autoimmune disease. In a previous longitudinal whole genome sequenci...
Үндсэн зохиолчид: | Clifford, R, Louis, T, Robbe, P, Ackroyd, S, Burns, A, Timbs, A, Wright Colopy, G, Dreau, H, Sigaux, F, Judde, J, Rotger, M, Telenti, A, Lin, Y, Pasero, P, Maelfait, J, Titsias, M, Cohen, DR, Henderson, S, Ross, M, Bentley, D, Hillmen, P, Pettitt, A, Rehwinkel, J, Knight, S, Taylor, J |
---|---|
Формат: | Journal article |
Хэл сонгох: | English |
Хэвлэсэн: |
American Society of Hematology
2014
|
Ижил төстэй зүйлс
Ижил төстэй зүйлс
-
SAMHD1, A Putative Tumour Suppressor, Is Recurrently Mutated in Chronic Lymphocytic Leukaemia, and Is Associated with Poor Risk Features
-н: Clifford, R, зэрэг
Хэвлэсэн: (2012) -
Restriction by SAMHD1 limits cGAS/STING-dependent innate and adaptive immune responses to HIV-1
-н: Maelfait, J, зэрэг
Хэвлэсэн: (2016) -
SAMHD1-dependent retroviral control and escape in mice.
-н: Rehwinkel, J, зэрэг
Хэвлэсэн: (2013) -
SAMHD1-dependent retroviral control and escape in mice
-н: Rehwinkel, J, зэрэг
Хэвлэсэн: (2013) -
A dual role for SAMHD1 in regulating HBV cccDNA and RT-dependent particle genesis
-н: Wing, P, зэрэг
Хэвлэсэн: (2019)